Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 455 of 1,261

  1. US 10501526

    Human antibodies to Ebola virus glycoprotein

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  2. US 10501551

    Multivalent and multispecific 41BB-binding fusion proteins

    Inhibrx, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  3. US 10501515

    Hepcidin analogues and uses thereof

    Protagonist Therapeutics, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  4. US 10501516

    Peptide compound

    Takeda Pharmaceutical Company Limited · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  5. US 10501507

    Griffithsin mutants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  6. US 10501500

    Methods of detection and removal of rhabdoviruses from cell lines

    Takeda Vaccines, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  7. US 10501490

    Taccalonolide microtubule stabilizers

    The Board of Regents of the University of Texas System · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  8. US 10501504

    Adhesin as immunogen against enterotoxigenic Escherichia coli

    United States of America as represented by the Secretary of the Air Force · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  9. US 10501470

    Use of asarinin in preparation of medicines for treating various coughs

    THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  10. US 10501482

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  11. US 10501428

    Thymoquinone derivatives for treatment of cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  12. US 10500281

    Injectable long-acting local anesthetic semi-solid formulations and its compositions

    MIRA PHARMA CORPORATION · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  13. US 10501435

    Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity

    Northwestern University · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  14. US 10500290

    Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  15. US 10500269

    Human rotavirus vaccine strains and diagnostics

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  16. US 10500262

    Synthetic antigen constructs against Campylobacter jejuni

    United States of America as represented by the Secretary of the Air Force · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  17. US 10500271

    Compositions and methods for self-adjuvanting vaccines against microbes and tumors

    The Regents of the University of California · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  18. US 10500256

    Polymers for delivery of therapeutic proteins

    The Board of Regents of the University of Texas System · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  19. US 10500246

    Compositions for delivery to and treatment of atherosclerotic plaques

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  20. US 10500229

    Targeted disruption of the MHC cell receptor

    Sangamo Therapeutics, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  21. US 10500218

    Uptake of pharmaceuticals within cyclodextrin-based porous materials

    Northwestern University · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  22. US 10500216

    Optimizing mifepristone absorption

    Corcept Therapeutics Incorporated · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  23. US 10500208

    Emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  24. US 10500238

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.